Denali Therapeutics
DNLI
DNLI
58 hedge funds and large institutions have $1.2B invested in Denali Therapeutics in 2018 Q1 according to their latest regulatory filings, with 28 funds opening new positions, 14 increasing their positions, 8 reducing their positions, and 15 closing their positions.
Holders
58
Holders Change
+13
Holders Change %
+28.89%
% of All Funds
1.33%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.09%
New
28
Increased
14
Reduced
8
Closed
15
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
1
BlackRock
New York
|
$20.8M |
2 |
2
BAMCO Inc
New York
|
$18M |
3 |
3
T. Rowe Price Associates
Baltimore,
Maryland
|
$7.32M |
4 |
4
Lord, Abbett & Co
Jersey City,
New Jersey
|
$5.6M |
5 |
5
Baillie Gifford & Co
Edinburgh,
United Kingdom
|
$102M |